• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    87 Biggest Movers From Yesterday

    3/10/22 4:57:25 AM ET
    $ABVC
    $ACY
    $ADES
    $AFIB
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Major Chemicals
    Industrials
    Get the next $ABVC alert in real time by email

    Gainers

    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) shares jumped 150% to close at $3.80 on Wednesday. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to Nasdaq at $4.25 per unit.
    • Direct Digital Holdings, Inc. (NASDAQ:DRCT) climbed 107.5% to settle at $2.49. Benchmark initiated coverage on Direct Digital with a Buy rating and announced a price target of $8.
    • Revelation Biosciences, Inc. (NASDAQ:REVB) gained 83.8% to settle at $1.70.
    • Sentage Holdings Inc. (NASDAQ:SNTG) rose 58.8% to close at $1.62 in sympathy with the overall market amid continued volatility on Ukraine-Russia concerns.
    • AST SpaceMobile, Inc. (NASDAQ:ASTS) climbed 44.9% to settle at $9.78 after the company announced it has signed a multi-launch agreement with SpaceX for planned direct-to-cell phone connectivity.
    • Cano Health, Inc. (NYSE:CANO) shares rose 43.2% to close at $6.53 after Third Point reported in a 13D filing a 6.7% stake in Cano Health.
    • CPS Technologies Corporation (NASDAQ:CPSH) surged 42.1% to close at $4.2850 in sympathy with the overall market amid continued volatility on Ukraine-Russia concerns.
    • Bumble Inc. (NASDAQ:BMBL) climbed 41.9% to close at $23.64 after the online dating company reported fourth-quarter results, which showed a 29% increase in Bumble App paying users. Bumble App revenue increased 42.2% year-over-year.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) jumped 41.9% to close at $1.38. TC BioPharm, on Tuesday, disclosed positive Phase 1b/2a data in late-stage Acute Myeloid Leukemia patients treated with allogeneic gamma delta T cells.
    • TherapeuticsMD, Inc. (NASDAQ:TXMD) gained 41.9% to close at $0.40. TherapeuticsMD recently announced it would sell its vitaCare business to GoodRx for $150 million.
    • Longeveron Inc. (NASDAQ:LGVN) jumped 39.7% to close at $7.07.
    • American Rebel Holdings, Inc. (NASDAQ:AREB) rose 39.1% to close at $1.60 after declining 13% on Tuesday.
    • Hudson Technologies, Inc. (NASDAQ:HDSN) jumped 34.9% to close at $5.37 after the company reported record Q4 and year end 2021 results.
    • Acutus Medical, Inc. (NASDAQ:AFIB) gained 30.7% to settle at $1.830 following a report suggesting newsletter provider Banyan Hill named the stock as a buy.
    • Lightbridge Corporation (NASDAQ:LTBR) surged 30% to close at $12.49.
    • Hour Loop, Inc. (NASDAQ:HOUR) gained 28.9% to close at $2.63.
    • Jianpu Technology Inc. (NYSE:JT) jumped 28.5% to close at $1.49.
    • Society Pass Incorporated (NASDAQ:SOPA) gained 27.8% to close at $2.80.
    • ABVC BioPharma, Inc. (NASDAQ:ABVC) gained 27.8% to settle at $2.94.
    • Bone Biologics Corporation (NASDAQ:BBLG) gained 27.6% to close at $1.94 following Zack Morris tweet.
    • Insignia Systems, Inc. (NASDAQ:ISIG) gained 27.2% to close at $8.52 after the company reported fourth-quarter financial results.
    • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) rose 26.4% to settle at $3.30.
    • Dada Nexus Limited (NASDAQ:DADA) jumped 25.8% to close at $8.10 after the company reported Q4 earnings results.
    • Ebix, Inc. (NASDAQ:EBIX) gained 25.7% to close at $31.89 following strong quarterly sales.
    • Gaotu Techedu Inc. (NYSE:GOTU) jumped 23.6% to close at $1.94. Gaotu Techedu recently reported Q4 earnings results.
    • HeartCore Enterprises, Inc. (NASDAQ:HTCR) rose 23.5% to settle at $2.47.
    • FIGS, Inc. (NYSE:FIGS) gained 23.2% to close at $17.29 after the company reported better-than-expected Q4 EPS and sales results.
    • Verastem, Inc. (NASDAQ:VSTM) surged 23.2% to settle at $1.38 after Truist Securities initiated coverage on the stock with a Buy rating and a $6 price target.
    • Exela Technologies, Inc. (NASDAQ:XELA) gained 23.2% to close at $0.77.
    • Mesoblast Limited (NASDAQ:MESO) jumped 22.9% to close at $4.40.
    • Mainz Biomed B.V. (NASDAQ:MYNZ) gained 22.6% to close at $14.00 after reporting year end 2021 results.
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) jumped 21.8% to close at $5.74. Rubius Therapeutics, last month, posted a Q4 loss of $0.61 per share.
    • Smart for Life, Inc. (NASDAQ:SMFL) gained 21.6% to close at $1.00.
    • Fluent, Inc. (NASDAQ:FLNT) rose 21.6% to close at $1.80 after the company reported better-than-expected Q4 adjusted EPS and sales results.
    • AutoWeb, Inc. (NASDAQ:AUTO) gained 21.1% to close at $2.12.
    • CareMax, Inc. (NASDAQ:CMAX) climbed 21% to close at $7.26.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) gained 21% to close at $7.43.
    • Boqii Holding Limited (NYSE:BQ) rose 20.7% to settle at $0.59.
    • Bakkt Holdings, Inc. (NASDAQ:BKKT) gained 20.1% to close at $5.62.
    • Vaccinex, Inc. (NASDAQ:VCNX) jumped 19.3% to settle at $1.30.
    • Imperial Petroleum Inc.. (NASDAQ:IMPP) gained 19.1% to close at $5.06. Imperial Petroleum announced an agreement to acquire 2 product tankers for $31 million.
    • MongoDB, Inc. (NASDAQ:MDB) gained 18.6% to close at $334.09 after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 and FY23 EPS and sales guidance above analyst estimates.
    • Dave Inc. (NASDAQ:DAVE) gained 18.4% to close at $5.16.
    • Natura &Co Holding S.A. (NASDAQ:NTCO) surged 17.7% to settle at $9.59 after JP Morgan upgraded the stock from Underweight to Neutral and announced a $10 price target.
    • iHuman Inc. (NYSE:IH) rose 17.2% to settle at $2.39.
    • Diversey Holdings, Ltd. (NASDAQ:DSEY) gained 15.3% to close at $8.65 after the company reported better-than-expected Q4 EPS results.
    • C4 Therapeutics, Inc. (NASDAQ:CCCC) jumped 15.3% to close at $24.21. C4 Therapeutics reported FDA orphan drug designation for CFT8634 for the treatment of soft tissue sarcoma.
    • Surrozen, Inc. (NASDAQ:SRZN) rose 14.4% to close at $2.86.
    • Pintec Technology Holdings Limited (NASDAQ:PT) rose 13.6% to close at $0.4773.
    • Kanzhun Limited (NASDAQ:BZ) rose 13.6% to settle at $24.26 after the company announced a share repurchase program of up to $150 million.
    • MOGU Inc. (NYSE:MOGU) rose 12.8% to close at $0.3089.
    • ECMOHO Limited (NASDAQ:MOHO) shares surged 12.4% to close at $0.24.
    • TDH Holdings, Inc. (NASDAQ:PETZ) rose 9.7% to close at $0.3436 after declining around 6% on Tuesday.
    • Lilium N.V. (NASDAQ:LILM) rose 8.6% to close at $4.29 after the company signed an MoU with NetJets for the right to purchase up to 150 Lilium aircraft.
    • Indonesia Energy Corporation Limited (NASDAQ:INDO) gained 8.6% to close at $33.65. Noble Capital Markets, on Tuesday, downgraded the stock from Outperform to Underperform.
    • AeroCentury Corp. (NYSE:ACY) rose 8.5% to close at $3.45.
    • HCI Group, Inc. (NYSE:HCI) surged 7.8% to close at $64.25 following Q4 results.
    • FTC Solar, Inc. (NASDAQ:FTCI) rose 6.2% to close at $5.65 after gaining 14% on Tuesday.


    Losers

    • Hycroft Mining Holding Corporation (NASDAQ:HYMC) dipped 37% to close at $0.63 on Wednesday after jumping 203% on Tuesday.
    • Natera, Inc. (NASDAQ:NTRA) shares fell 32.8% to close at $36.80 after Hindenburg Research issued a short report on the stock.
    • Cyren Ltd. (NASDAQ:CYRN) dipped 31.9% to close at $7.09 after jumping over 45% on Tuesday.
    • Invacare Corporation (NYSE:IVC) dropped 31.6% to settle at $1.60 following Q4 results.
    • Enservco Corporation (NYSE:ENSV) fell 28.1% to close at $3.02.
    • U.S. Well Services, Inc. (NASDAQ:USWS) fell 26.9% to close at $1.28. US Well Services priced its 14.18 million share offering at $1.763 per share.
    • Nine Energy Service, Inc. (NYSE:NINE) shares fell 21.4% to close at $4.45. Nine Energy Service shares jumped 58% on Tuesday after the company reported better-than-expected Q4 results.
    • Independence Contract Drilling, Inc. (NYSE:ICD) dropped 21.2% to close at $5.57.
    • Intrusion Inc. (NASDAQ:INTZ) fell 21.1% to close at $2.99.
    • ENGlobal Corporation (NASDAQ:ENG) dipped 20.2% to close at $1.6450.
    • MDJM Ltd (NASDAQ:MDJH) fell 20.1% to settle at $1.95.
    • Ecoark Holdings, Inc. (NASDAQ:ZEST) fell 20% to close at $2.44.
    • MV Oil Trust (NYSE:MVO) fell 19.9% to close at $11.68.
    • Smart Sand, Inc. (NASDAQ:SND) fell 19.8% to settle at $3.53 after the company reported worse-than-expected Q4 EPS results.
    • OceanPal Inc. (NASDAQ:OP) fell 18.9% to close at $0.90 after dropping 12% on Tuesday.
    • Superior Drilling Products, Inc. (NYSE:SDPI) dropped 18.8% to settle at $1.30.
    • Sky Harbour Group Corporation (NASDAQ:SKYH) fell 18% to close at $24.50.
    • Westport Fuel Systems Inc. (NASDAQ:WPRT) fell 17.2% to settle at $1.68 after climbing over 52% on Tuesday.
    • Cricut, Inc. (NASDAQ:CRCT) fell 16.7% to settle at $11.61 after the company reported worse-than-expected Q4 sales results.
    • Evolve Transition Infrastructure LP (NASDAQ:SNMP) dipped 15.8% to close at $0.8083.
    • Ontrak, Inc. (NASDAQ:OTRK) fell 15% to close at $2.16 after the company reported worse-than-expected Q4 sales results and issued FY22 sales guidance below analyst estimates.
    • SilverSun Technologies, Inc. (NASDAQ:SSNT) fell 14.4% to close at $3.70.
    • Kinetik Holdings Inc. (NASDAQ:KNTK) dropped 12.2% to close at $61.36 after the company priced its upsized secondary offering of about 3.48 million shares at $58 per share.
    • Advanced Emissions Solutions, Inc. (NASDAQ:ADES) dropped 10.9% to close at $5.63. Advanced Emissions Solns posted Q4 sales of $23.30 million.
    • ION Geophysical Corporation (NYSE:IO) shares fell 9.5% to close at $1.05 after dropping over 16% on Tuesday.
    • Tsakos Energy Navigation Limited (NYSE:TNP) shares fell 9.3% to close at $9.20 as oil prices pulled back following recent strength. The sector has gained amid supply concerns as a result of the Russia-Ukraine conflict and a US ban on Russian oil imports.
    • Yext, Inc. (NYSE:YEXT) fell 9.3% to close at $5.37 after the company reported worse-than-expected Q4 sales results. The company also issued Q1 EPS and sales guidance below analyst estimates.
    • Great Panther Mining Limited (NYSE:GPL) fell 8.2% to close at $0.3299 after gaining around 35% on Tuesday.
    • Stitch Fix, Inc. (NASDAQ:SFIX) fell 6.1% to close at $10.34. Stitch Fix posted upbeat revenue for its second quarter, but issued weak sales guidance for the current quarter.
    Get the next $ABVC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABVC
    $ACY
    $ADES
    $AFIB

    CompanyDatePrice TargetRatingAnalyst
    FIGS Inc.
    $FIGS
    2/27/2026$17.00Sector Weight → Overweight
    KeyBanc Capital Markets
    FIGS Inc.
    $FIGS
    2/27/2026$9.00 → $15.00Market Perform
    Telsey Advisory Group
    MongoDB Inc.
    $MDB
    2/26/2026$455.00 → $400.00Outperform
    BMO Capital Markets
    Surrozen Inc.
    $SRZN
    2/19/2026$40.00Overweight
    Cantor Fitzgerald
    Dave Inc.
    $DAVE
    2/9/2026Outperform
    Keefe Bruyette
    Kinetik Holdings Inc.
    $KNTK
    2/6/2026$43.00Buy → Hold
    Jefferies
    Verastem Inc.
    $VSTM
    2/4/2026$18.00Buy
    H.C. Wainwright
    Kinetik Holdings Inc.
    $KNTK
    1/27/2026Outperform → Peer Perform
    Wolfe Research
    More analyst ratings

    $ABVC
    $ACY
    $ADES
    $AFIB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    FIGS, Inc. upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded FIGS, Inc. from Sector Weight to Overweight and set a new price target of $17.00

    2/27/26 8:21:04 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on FIGS, Inc. with a new price target

    Telsey Advisory Group reiterated coverage of FIGS, Inc. with a rating of Market Perform and set a new price target of $15.00 from $9.00 previously

    2/27/26 8:07:13 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    BMO Capital Markets reiterated coverage on MongoDB with a new price target

    BMO Capital Markets reiterated coverage of MongoDB with a rating of Outperform and set a new price target of $400.00 from $455.00 previously

    2/26/26 6:51:04 AM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    $ABVC
    $ACY
    $ADES
    $AFIB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Signatera™ MRD Data at ASCO GU Highlights Potential Utility Across GU Cancers, Including for Bladder Preservation

    11 scientific abstracts, including 4 oral presentations and a concurrent publication in Nature Medicine, underscore how Signatera MRD can improve quality of life for patients with genitourinary cancers Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, today announced it will present new data in genitourinary malignancies at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), taking place February 26-28, 2026. Across four oral presentations in muscle-invasive bladder cancer (MIBC), these data reinforce Signatera's role in identifying patients who benefit from adjuvant immunotherapy, supporting response-adaptive bladder p

    2/27/26 10:05:00 AM ET
    $NTRA
    Medical Specialities
    Health Care

    Bakkt Announces Pricing of $48.125 Million Registered Direct Offering

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bakkt, Inc. ("Bakkt" or the "Company") (NYSE:BKKT) today announced the pricing of a registered direct offering of 3,024,799 shares of Class A common stock and pre-funded warrants to purchase up to 2,475,201 shares of Class A common stock at a price of $8.75 per share and $8.7499 per pre-funded warrant, which represents the per share price of each share of Class A common stock less the $0.0001 per share exercise price for each pre-funded warrant. The offering to a single institutional investor is expected to close on or around March 2, 2026, subject to customary closing conditions. The gross proceeds from the offering, before deducting placement a

    2/27/26 7:32:49 AM ET
    $BKKT
    Finance: Consumer Services
    Finance

    Ryoncil® Profits Underpinning Substantial Growth Pipeline

    NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today provided financial results and an operational update for the period ended December 31, 2025 (H1 FY2026). FINANCIAL HIGHLIGHTS FOR H1 FY20261 Performance driven by successful commercial launch of Ryoncil® Total revenue of US$51.3 million (A$78.3 million),2 up from US$3.2 million.Successful U.S. commercial launch of Ryoncil® (remestemcel-L-rknd) generated gross sales of US$57.0 million and revenue of US$48.7 million after gross to net adjustment.Ryoncil® gross profit, excluding amortization, was US$44.2 million versus nil in

    2/26/26 7:42:54 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABVC
    $ACY
    $ADES
    $AFIB
    SEC Filings

    View All

    SEC Form 6-K filed by Mesoblast Limited

    6-K - MESOBLAST LTD (0001345099) (Filer)

    2/27/26 9:18:59 AM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form POS AM filed by Lightbridge Corporation

    POS AM - LIGHTBRIDGE Corp (0001084554) (Filer)

    2/27/26 9:15:12 AM ET
    $LTBR
    Professional Services
    Consumer Discretionary

    SEC Form 424B5 filed by Bakkt Inc.

    424B5 - Bakkt, Inc. (0001820302) (Filer)

    2/27/26 7:38:16 AM ET
    $BKKT
    Finance: Consumer Services
    Finance

    $ABVC
    $ACY
    $ADES
    $AFIB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel and Secretary D'Annunzio Marc sold $7,924 worth of shares (785 units at $10.09), decreasing direct ownership by 0.66% to 117,833 units (SEC Form 4)

    4 - Bakkt, Inc. (0001820302) (Issuer)

    2/27/26 5:49:38 PM ET
    $BKKT
    Finance: Consumer Services
    Finance

    SEC Form 3 filed by new insider Khajehnouri Nima

    3 - Dave Inc./DE (0001841408) (Issuer)

    2/26/26 10:59:52 AM ET
    $DAVE
    Finance: Consumer Services
    Finance

    Officer Ellis Lindsay was granted 10,676 shares, increasing direct ownership by 33% to 43,093 units (SEC Form 4)

    4 - Kinetik Holdings Inc. (0001692787) (Issuer)

    2/24/26 6:11:59 PM ET
    $KNTK
    Natural Gas Distribution
    Utilities

    $ABVC
    $ACY
    $ADES
    $AFIB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Sprott Eric bought $6,307,500 worth of shares (150,000 units at $42.05) (SEC Form 4)

    4 - HYCROFT MINING HOLDING CORP (0001718405) (Issuer)

    2/23/26 6:34:48 PM ET
    $HYMC
    Precious Metals
    Basic Materials

    Large owner Tcg Crossover Gp Ii, Llc bought $444,844 worth of shares (18,856 units at $23.59) (SEC Form 4)

    4 - Surrozen, Inc./DE (0001824893) (Issuer)

    2/13/26 4:19:53 PM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Tcg Crossover Gp Ii, Llc bought $202,534 worth of shares (9,357 units at $21.65) (SEC Form 4)

    4 - Surrozen, Inc./DE (0001824893) (Issuer)

    2/3/26 8:03:54 PM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABVC
    $ACY
    $ADES
    $AFIB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-6) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 12/28/2021. Application Category: NDA, Application Number: 210132, Application Classification: Efficacy

    12/29/21 7:23:57 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IMVEXXY issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug IMVEXXY (SUPPL-2) with active ingredient ESTRADIOL has changed to 'Approval' on 11/16/2021. Application Category: NDA, Application Number: 208564, Application Classification: Labeling

    11/17/21 4:38:32 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-3) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 06/22/2021. Application Category: NDA, Application Number: 210132, Application Classification: Labeling

    6/24/21 5:13:50 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ACY
    $ADES
    $AFIB
    Financials

    Live finance-specific insights

    View All

    Dave to Report Fourth Quarter and Full Year 2025 Results and Participate in Upcoming Investor Conferences

    LOS ANGELES, CA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced its participation in two upcoming investor conferences following the Company's fourth quarter and full year 2025 earnings conference call on Monday, March 2, 2026, at 5:00 p.m. Eastern time. The earnings conference call and investor conference details are as follows: Earnings Conference Call Date: Monday, March 2, 2026Time: 5:00 p.m. Eastern timeConference Call Registration: linkWebcast: link The conference call will also be available for replay in the Events section of the Company's website, along with the transcript, at https://in

    2/26/26 4:15:00 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    FIGS Releases Fourth Quarter and Full Year 2025 Financial Results

    Exceeded Top and Bottom Line Expectations Grew Q4 2025 Net Revenues 33.0% to a Record $201.9 Million Achieved Q4 2025 Net Income Margin of 9.2% and Adjusted EBITDA Margin of 13.2% Plans Low Double-Digit Net Revenues Growth and Margin Expansion in FY 2026 FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its fourth quarter and full year 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Fourth Quarter 2025 Financial Highlights Net revenues were $201.9 million, an in

    2/26/26 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Natera Reports Fourth Quarter and Full Year 2025 Financial Results

    Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the fourth quarter and full year ended December 31, 2025. Recent Financial Highlights Generated total revenues of $665.5 million in the fourth quarter of 2025, compared to $476.1 million in the fourth quarter of 2024, an increase of 39.8%. Product revenues grew 39.8% over the same period. Generated a gross margin1 of 66.9% in the fourth quarter of 2025, compared to a gross margin1 of 62.9% in the fourth quarter of 2024. Generated total revenues of $2,306.1 million in the full year 2025, compared to $1,696.9 million in the full year 2024, an increase of 35.9%.

    2/26/26 4:05:00 PM ET
    $NTRA
    Medical Specialities
    Health Care

    $ABVC
    $ACY
    $ADES
    $AFIB
    Leadership Updates

    Live Leadership Updates

    View All

    Employ Inc. Appoints Jerry Jao as CEO

    DENVER, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Employ Inc., a leading provider of people-first, intelligent hiring solutions across JazzHR, Lever, and Jobvite, today announced the appointment of Jerry Jao as CEO. Jao is a successful serial entrepreneur who founded three businesses, including the AI-powered marketing and personalization SaaS company ReSci (Retention Science), acquired by Constant Contact in 2020. During his executive career, he first encountered Employ as a Lever customer and spent six years using the platform, gaining firsthand insight into how its innovation helps hiring managers stay organized and save time across the hiring process. Jao shared, "Hiring has never needed to

    2/18/26 8:00:00 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Longeveron® Appoints Stephen H. Willard as Chief Executive Officer

    Mr. Willard has a 30+ year track record of leadership across public and private sectors as CEO of multiple biotechnology and pharmaceutical firms, with an impressive history of delivering significant fundraises and strategic collaborationsCorporate focus on delivering top-line results from the pivotal Phase 2b clinical trial in Hypoplastic Left Heart Syndrome (HLHS), anticipated in the third quarter of 2026 Than Powell stepped down as interim CEO; will remain with the Company to support the leadership transition and continue his work in the Company's on-going business development activities MIAMI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage regenerati

    2/13/26 4:30:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    $ABVC
    $ACY
    $ADES
    $AFIB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Acutus Medical Inc.

    SC 13D/A - Acutus Medical, Inc. (0001522860) (Subject)

    12/16/24 9:52:56 PM ET
    $AFIB
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13G/A filed by Mesoblast Limited

    SC 13G/A - MESOBLAST LTD (0001345099) (Subject)

    12/16/24 12:08:07 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Enservco Corporation

    SC 13D/A - Enservco Corp (0000319458) (Subject)

    12/10/24 4:00:16 PM ET
    $ENSV
    Oilfield Services/Equipment
    Energy